Neuroblastoma cell culture: membrane changes during cyclic AMP-induced morphological differentiation.
D001593:Benzyl Compounds / Q000494:pharmacology; D001665:Binding Sites; D002087:Butyrates / Q000494:pharmacology; D002449:Cell Aggregation / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002999:Clone Cells; D003208:Concanavalin A / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology*; D004987:Ethers / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D037102:Lectins / Q000494:pharmacology; D009447:Neuroblastoma / Q000473:pathology*; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D001593:Benzyl Compounds; D002087:Butyrates; D004987:Ethers; D007093:Imidazoles; D007659:Ketones; D037102:Lectins; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins; D003208:Concanavalin A; D000242:Cyclic AMP; D014357:Trypsin